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Patients (pts) with history of paroxysmal supraventricular tachycardia
(PSVT) have a higher risk of atrial fibrillation (AF) than other pts. The pur-
pose of the study was to evaluate the incidence of AF in pts seen for PSVT
and to look for the factors of AF.
 
Population:
 
 1099 pts aged from 5 to 85 years were consecutively studied
for spontaneous PSVT that was confirmed by electrophysiological study
(EPS). Pts with anterograde conduction through an accessory pathway were
excluded.
 
Methods:
 
 The history of spontaneous AF was noted. Clinical factors (age,
gender, heart disease) and electrophysiological factors were noted. Pts with
and without AF were compared.
 
Results:
 
 62 pts developed documented paroxysmal or permanent AF or
flutter (6 %). Several clinical factors were associated with AF: pts were
older than 1037 pts without AF (59±13 years vs 50±19, p < 0.0009); they
were more frequently men (35/62; 56 %) than other pts 383/1037; 37 %)
(p < 0.002). Associated heart disease (HD) (ischemic, valvular, hyperten-
sive HD) was more frequent in pts with AF (17/62; 27 %) than in pts
without AF (66/1037; 6 %) (p < 0.0000). There were no differences at EPS
concerning the mechanism of reentry: typical atrioventricular (AV) node
re-entrant tachycardia (AVNRT) was noted in 48/62 pts with AF (77 %),
712/1037 pts without AF (69 %) (NS); reentry in a concealed accessory
pathway (AVRT) was noted in 8 pts with AF (14 %) and 191 pts without
AF (18 %) (NS); atypical AVNRT was noted in 6 pts with AF (10 %) and
134 pts without AF (13 %) (NS). The induction or the spontaneous occur-
rence of AF during electrophysiological study was more frequent in pts
with AF (17/62; 27 %) than in pts without AF (113/1037; 11 %)
(p < 0.00000). 
 
Conclusions:
 
 The incidence of AF was 6 % in 1099 consecutive patients
who had PSVT. The risk was correlated with the classical factors of AF, the
older age, the male gender and the presence of HD. The mechanism of the
reentry does not change the incidence of AF but the induction of AF is more
frequent than in other patients. Thus, patients with PSVT and with these risk
factors should be carefully followed.
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Full length 66kDa estrogen receptor alpha (ER) stimulates target gene tran-
scription through two activation functions (AF), AF-1 in the N-terminal
domain and AF-2 in the ligand binding domain. Another physiologically
expressed 46kDa ER isoform lacks the N-terminal A/B domains and is conse-
quently devoid of AF-1. To evaluate the involvement of ER AF-1 and AF-2
in the vasculoprotective actions of  estradiol (E2), we generated a targeted
deletion of the ER A/B domain in the mouse named ERAF-10 mice, and a tar-
geted deletion of amino acids 543-549 and thus deficient in AF-2 (named
ERAF-20 mice). 
Both basal endothelial NO production was increased by E2 administration
in a similar extent than in control mice. E2 similarly decreased fatty streak
deposits at the aortic root from both ovariectomized 18 week-old ERAF-1+/+
LDL-r-/- (Low Density Lipoprotein receptor) and ERAF-10 LDL-r-/- mice fed
with a hypercholesterolemic diet. We conclude that ER AF-1 is not required
for the vasculoprotective actions of E2, whereas it is necessary for the effects
of E2 on its reproductive targets. Thus, Selective Estrogen Receptor Modula-
tors stimulating ER independently of the A/B domain and thereby with min-
imal activation of ER AF-1 could retain beneficial vascular actions, while
minimizing the sexual effects. 
The results concerning ERAF-20 mice are in process and will be available
at the end of 2010, and the precise role of AF2 in these actions will be pre-
sented.
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Cardiovascular and metabolic consequences of overweight are a growing
concern in both western and developing countries. Several studies in mice
have shown that postnatal overfeeding (OF) induces permanent moderate
increase of body weight in the adult life; however, cardiovascular repercus-
sions of postnatal OF are less known.
Immediately after birth, and during 3 weeks, litters of C57BL/6 mice were
either maintained at 10 (normal-fed group, NF), or reduced to 3 in order to
induce an OF situation. At weaning, mice of both groups received a standard
diet. Measurements of body weight, and metabolic parameters (cholesterol,
insulin and leptin) were performed in the plasma at 7 months. Cardiac func-
tion was assessed by echocardiography and the susceptibility to myocardial
global ischemia and reperfusion was assessed ex vivo in isolated perfused
heart.
OF led to an increase in body weight (+30%) as compared to NF group. Sig-
nificant increases of plasma cholesterol (0.67 vs 0.78 g/l, p<0.05), insulin
(0.98 vs 1.63 ng/ml, p<0.05) and leptin (0.39 vs 0.91 ng/ml, p<0.05) levels
were observed in OF mice as compared to NF mice. In vivo, diastolic (97 vs
114 mmHg, p<0.05) and systolic (126 vs 140 mmHg) blood pressure were
significantly higher in OF mice than NF mice. Moreover, LV shortening and
ejection fraction were decreased in OF mice. Ex vivo, after 30 minutes of
ischemia, hearts isolated from mice that underwent postnatal OF showed
lower recovery of coronary flow (35% vs 55%, p<0.05), of developed ven-
tricular pressure, of +dP/dt and -dP/dt. Moreover, infarct size evaluated after
2 hours of reperfusion was increased in OF group (31% vs 54%, p<0.05) as
compared to NF.
These results show that OF induces metabolic and functional disturbances
but also a higher susceptibility to cardiac functional damage after ischemia ex
vivo. Complementary data are required to understand the cellular pathways
implicated in these metabolic and cardiovascular modifications. 
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Background:
 
 Endothelial colony-forming cells (ECFCs) have proliferative
and vasculogenic capacities and can be detected in patients (pts) with myocar-
dial infarction (MI). High ECFC levels reportedly lead to positive left ventric-
